Barclays lowered the firm’s price target on Kenvue (KVUE) to $17 from $20 and keeps an Equal Weight rating on the shares. The firm adjusted models to reflect “muted and decelerating” growth in parts of the personal care space since the Q2 reports.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- Kenvue Inc call volume above normal and directionally bullish
- Trump Weekly: President threatens new tariffs, announces TikTok deal
- Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
- Moderately bullish activity in Kenvue Inc with shares up 0.4%
- Trump tells pregnant women ‘don’t use Tylenol unless absolutely necessary’